Company
Avicenna Biosciences
Also known as Avicenna Biosciences, Inc.
- Business model
- B2B
- Legal name
- Avicenna Biosciences, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development.
Funding snapshot
- Total raised
- $17.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $6M2024-07-01
Funding rounds
- Round, 2024
- $6M2024-07-01, SEC form D sold, 1 investor
- Round, 2023
- $6M2023-11-03, SEC form D sold, 1 investor
- Round, 2022
- $3M2022-04-15, SEC form D sold, 1 investor
- Round, 2022
- $70.7K2022-02-17, SEC form D sold, 1 investor
- Round, 2020
- $2.5M2020-08-28, SEC form D sold, 1 investor
Loading relationship preview